Cart
sales@molnova.com
PF-4776548
CAS No. 1515856-61-7
PF-4776548( PF-04776548 )
Catalog No. M12117 CAS No. 1515856-61-7
PF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-4776548
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.
-
DescriptionPF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.
-
In Vitro——
-
In Vivo——
-
SynonymsPF-04776548
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1515856-61-7
-
Formula Weight341.342
-
Molecular FormulaC18H16FN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(3-(4-fluoro-2-methoxy-benzyl)-7-hydroxy-8,9-dihydro-3H,7H-pyrrolo[2,3-c][1,7]naphthyridin-6-one)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Harrison A, et al. Xenobiotica. 2012 Jan;42(1):57-74.
molnova catalog
related products
-
(±)-BI-D
A potent, allosteric HIV integrase inhibitor (Kd=34 nM) that binds the LEDGF/p75 binding site on integrase.
-
I-XW-053
I-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-NTD interface) with micromolar affinity.
-
Anagrelide HCl
Anagrelide Hydrochloride(BL4162A) is a drug used for the treatment of essential thrombocytosis.
